[ XXXX in haematological @entity5 in the medical intensive care unit].

@entity1 @entity2803 @entity55 @entity5 @entity205 @entity364 @entity358 @entity1800 @entity1576 @entity4005 @entity288
30 @entity1 with @entity5 and @entity55 , treated during a three-year period in the medical intensive care unit (ICU) of a university hospital, were studied in retrospect. Twelve @entity1 had received bone marrow or peripheral stem cell transplantations 90 +/- 143 (10 - 546) days prior to ICU admission. Six of these received @entity205 . 19 of 30 @entity1 were on @entity288 and 20 had received courses of chemotherapy within a period of one month prior to ICU admission. @entity1 presented with signs of @entity358 and @entity1576 . In 24 @entity1 the likely causative pathogen for @entity55 could be identified. Gram-negative bacteria (n = 17) were in the majority, lead by Pseudomonas, Enterobacter, and @entity4005 species. Gram-positive bacteria (n = 5) were Streptococcus and Staphylococcus species. Infections with Chlamydiae species were diagnosed in two cases. @entity364 were caused by Candida (n = 8) or Aspergillus species (n = 3) and @entity1800 by @entity2803 (n = 6). Infections with more than one pathogen were common. Ten @entity1 had @entity55 associated with signs of diffuse pulmonary parenchymal damage of varying degree. 26 @entity1 received mechanical ventilation for 7 +/- 9 (1 - 32) days. The duration of stay in the ICU was 11 +/- 10 (1 - 43) days. 26 of the 30 @entity1 (87 %) died. @entity1 with haematological @entity5 and @entity55 have despite medical intensive care treatment a poor prognosis with substantial mortality.
